Cerebral Collateral Circulation: A Review in the Context of Ischemic Stroke and Mechanical Thrombectomy.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 20 08 2018
revised: 06 10 2018
accepted: 08 10 2018
pubmed: 21 10 2018
medline: 8 3 2019
entrez: 21 10 2018
Statut: ppublish

Résumé

The pial (leptomenigeal) collateral circulation is a key determinant of functional outcome after mechanical thrombectomy after large-vessel ischemic stroke. Patients with good collateral blood flow benefit up to 24 hours after stroke onset, whereas those with poor collateral flow evidence less or no benefit. However, clues to why collateral flow varies so widely among patients have remained elusive. Recent findings in animal studies, which are currently being tested for confirmation in humans, have found that naturally occurring variants of a novel "collateral gene," Rabep2, result in large differences in the extent of anatomic collaterals and thus blood flow and infarct size in mice after stroke. The comprehension of collagerogenesis in humans and the evaluation of collateral status could aid in identifying patients who will benefit not only from mechanical thrombectomy in the extended time window but also from any reperfusion strategy. We performed a literature review focused on radiographic, clinical, and genetic aspects of the collateral circulation.

Identifiants

pubmed: 30342266
pii: S1878-8750(18)32363-5
doi: 10.1016/j.wneu.2018.10.066
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

33-42

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Guilherme Santos Piedade (GS)

Department of Neurosurgery, Geisinger, Pennsylvania, USA; Department of Neurosurgery, University of Düsseldorf, Düsseldorf, Germany.

Clemens M Schirmer (CM)

Department of Neurosurgery, Geisinger, Pennsylvania, USA.

Oded Goren (O)

Department of Neurosurgery, Geisinger, Pennsylvania, USA.

Hua Zhang (H)

Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, North Carolina, USA.

Amir Aghajanian (A)

Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, North Carolina, USA.

James E Faber (JE)

Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, North Carolina, USA.

Christoph J Griessenauer (CJ)

Department of Neurosurgery, Geisinger, Pennsylvania, USA; Research Institute of Neurointervention, Paracelsus Medical University, Salzburg, Austria; Department of Neurosurgery, Paracelsus Medical University, Salzburg, Austria. Electronic address: christoph.griessenauer@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH